Chronic Kidney Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People whose hemoglobin blood level is below 11 g/dL (a measure that indicates low red blood cell levels)
- People whose iron storage level in the blood (ferritin) is below 100 ng/ml, or whose transferrin saturation (a measure of how much iron is being carried in the blood) is below 20%
Who may not be able to join:
- People who weigh less than 50 kg or have a BMI below 17
- People who have had significant bleeding (more than 500 ml) in the 72 hours before joining the study
- People who have a blood cancer or other blood cell growth disease, or a condition called hemochromatosis (a disorder causing too much iron in the body)
- People who have had an active infection in the 30 days before joining the study
- People who have a long-term inflammatory condition affecting the whole body
- People living with HIV, Hepatitis C, or Hepatitis B
- People currently receiving iron treatment
- People who have had a blood transfusion in the 90 days before joining the study
- People who were hospitalised for a heart or cardiovascular problem in the 30 days before joining the study
- People taking blood-thinning medication known as coumarins (such as warfarin)
- People with chronic liver disease
- People taking medications that suppress the immune system
- People who have received treatments that stimulate red blood cell production, or who have had radiotherapy or chemotherapy in the 30 days before joining the study
- People who have a major surgery planned during the study period
- People who are pregnant or breastfeeding
- People with a drug addiction
- People who are currently participating in another clinical trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Juan Muñoz Castañeda, MD, Maimónides Biomedical Research Institute of Córdoba
Phone: 34 957010000
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
FGF23 on the induction of cardiovascular damage in anemia with and without CKD
Can't join this trial?
Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.